NewsBusiness News

Stock Movers

iHeartPodcasts

Listen for Short conversations on today's biggest winners and losers in the stock market.

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Play

Open in

428 episodes
Avg 4 min
English

Episodes 428

Newest Oldest Longest

All20 Unplayed20 In progress0 Played0

Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.

August 20 · 4 min
JD Sports Falls, Aegon Down, Trainline Drops
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - JD Sports Fashion Plc cut its profit outlook after weaker-than-expected sales of sneakers in the second quarter, as its customers grapple with cost-of-living pressures and pull back on discretionary spending. - Aegon shares fall as much as 4.5%, the worst drop since March, after the insurer released interim results. Analysts said operating capital generation and operating profit topped expectations, although mainly thanks to one-offs, and noted the stock’s strong performance leading into the print. - Trainline drops a further 5.7% on Thursday, extending strong declines after Wednesday’s announcement of a UK competition watchdog investigation into so-called drip pricing, as JPMorgan cuts its price target to a new Street-low. See omnystudio.com/listener for privacy information.
- Transcript
August 20 · 4 min
JD Sports Drops, Novonesis Gains, Sartorius Rises
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - JD Sports cut its profit outlook after weaker-than-expected sales of sneakers in the second quarter, as its customers grapple with cost-of-living pressures and pull back on discretionary spending. - Novonesis jumped to a more than one-year high in Copenhagen trading after the world’s largest maker of industrial enzymes raised its financial forecast and said it will buy back own stock for the first time. - Sartorius rises as much as 5.9%, the most in six weeks, after the stock was upgraded to buy from neutral at UBS. The German lab equipment maker is “well-positioned for accelerating growth” from 2027 to 2029, according to the broker. See omnystudio.com/listener for privacy information.
- Transcript
August 20 · 5 min
SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical Up
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - After SK Hynix unveiled its own program to buy back 40 trillion won ($29 billion) of stock, JPMorgan Chase & Co. said the company may follow that up with additional returns worth at least $130 billion. SK Hynix rose as much as 14.7%. - Kuaishou Tech shares drop as much as 12% in Hong Kong after the Chinese Internet firm gave weak guidance for the coming quarter that triggered a wave of analyst downgrades over concerns around weak macro conditions and policy tightening on online-streaming e-commerce. - Sino Biopharmaceutical and Asian healthcare firms are rising on the back of a skin cancer vaccine trial breakthrough by Moderna and Merck. See omnystudio.com/listener for privacy information.
- Transcript
August 19 · 5 min
Moderna Soars, SK Hynix Jumps, Estee Lauder Gains
Today's biggest winners and losers in the stock market, a look at the notable movers: On this episode of Stock Movers: -Moderna (MRNA) shares surged, delivering a $5.5 billion blow to short sellers who had bet that the vaccine maker's slump would continue. The company's stock price soared 177% after it said its personalized cancer vaccine helped reduce the recurrence of melanoma in a late-stage trial. The jump generated paper losses of about $5.5 billion for short sellers, bringing mark-to-market losses to roughly $7.7 billion this year, according to data from S3 Partners LLC. - SK Hynix (KS) unveiled plans to buy back 40 trillion won of shares and return more profits to investors, moving to stabilize its shares after they fell more than 50% in two months. The memory chipmaker will buy back as many as 24 million shares between Aug. 20 and Nov. 19 and cancel them, and raised its shareholder return pledge to more than 50% of cumulative free cash flow from 2025 to 2027. SK Hynix’s buyback plan is partly aimed at appeasing Korean retail investors who were upset by the company’s decision to issue new shares for its US listing, rather than through existing treasury stock, which diluted their local holdings. - Estée Lauder (EL) shares jumped after its results beat estimates and ended a run of three straight declines in annual revenue. The company reported revenue of $3.6 billion in its fiscal fourth quarter and adjusted earnings per share of $0.39, which topped expectations. The company reaffirmed guidance for organic net sales growth and raised guidance on its adjusted operating margin, with analysts saying a steady recovery is underway. See omnystudio.com/listener for privacy information.
- Transcript
August 19 · 7 min
Closing Bell: Moderna Surges, Estee Lauder Soars, TJ Maxx Declines
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Isabelle Lee, Carol Massar and Emily Graffeo - Moderna (MRNA) shares surged, delivering a $5.5 billion blow to short sellers who had bet that the vaccine maker's slump would continue. The company's stock price soared 177% after it said its personalized cancer vaccine helped reduce the recurrence of melanoma in a late-stage trial. The jump generated paper losses of about $5.5 billion for short sellers, bringing mark-to-market losses to roughly $7.7 billion this year, according to data from S3 Partners LLC. - Estée Lauder (EL) shares jumped after its results beat estimates and ended a run of three straight declines in annual revenue. The company reported revenue of $3.6 billion in its fiscal fourth quarter and adjusted earnings per share of $0.39, which topped expectations. The company reaffirmed guidance for organic net sales growth and raised guidance on its adjusted operating margin, with analysts saying a steady recovery is underway. - TJ Maxx (TJX) shares fall 0.84% in Wednesday trading after the clothing retailer reported second-quarter comparable sales for its Marmaxx segment, which includes TJ Maxx and Marshalls, that missed the average analyst estimate. See omnystudio.com/listener for privacy information.
- Transcript
August 19 · 3 min
SK Hynix Rises, Moderna Gains, Estee Lauder Soars as Results Show Turnaround Gaining Steam
On this episode of Stock Movers: -SK Hynix ADRs rose. SK Hynix Inc. unveiled plans to buy back 40 trillion won ($29 billion) of shares and return more profits to investors, moving to stabilize its shares after they fell more than 50% in two months. The memory chipmaker said it will buy back as many as 24 million shares between Aug. 20 and Nov. 19 and cancel them, according to a regulatory filing Wednesday. It also raised its shareholder return pledge to more than 50% of cumulative free cash flow from 2025 to 2027, equivalent to about $170 billion, according to Bloomberg calculations. -Moderna (MRNA) shares rise. A personalized vaccine developed by Moderna Inc. and Merck & Co. helped reduce the recurrence of melanoma in a large, late-stage trial. The trial met its main goal of showing that the vaccine, combined with Merck’s immune drug Keytruda, reduced melanoma recurrences more than the immunotherapy alone. The companies will discuss filing for approval with regulators and will present the data at an upcoming medical meeting, with Moderna Chief Executive Officer Stéphane Bancel saying the product could be approved as soon as 2027. -Estee Lauder (EL) shares jumped after its results beat estimates and ended a run of three straight declines in annual revenue. The company reported revenue of $3.6 billion in its fiscal fourth quarter and organic sales growth accelerated to 5%. The company reaffirmed guidance for organic net sales growth of 3% to 5% in its current fiscal year, and raised guidance on its adjusted operating margin. See omnystudio.com/listener for privacy information.
- Transcript
August 19 · 2 min
Moderna Rises, La-Z Boy Drops, Norfolk Southern Corp Climbs as Regulator Resumes Review of Bid From Rival
On this episode of Stock Movers: - Moderna (MRNA) shares rise. A personalized vaccine developed by Moderna Inc. and Merck & Co. helped reduce the recurrence of melanoma in a large, late-stage trial. The trial met its main goal of showing that the vaccine, combined with Merck’s immune drug Keytruda, reduced melanoma recurrences more than the immunotherapy alone. The companies will discuss filing for approval with regulators and will present the data at an upcoming medical meeting, with Moderna Chief Executive Officer Stéphane Bancel saying the product could be approved as soon as 2027. - La-Z Boy (LZB) shares tumble after the furniture maker’s forecast sales for the second quarter missed the average analyst estimate. KeyBanc Capital Markets analyst Bradley Thomas says the company “issued F2Q sales and implied EPS guidance below consensus, pressured in part by continued investments” - Norfolk Southern Corp (NSC) climbs after a federal regulator resumed its review of Union Pacific’s bid for the rival. The Surface Transportation Board established a procedural schedule for public comment, with participants having until Sept. 4 to file a notice of intent to participate in the review process. See omnystudio.com/listener for privacy information.
- Transcript
August 19 · 3 min
Moderna's Record Surge, Estee Lauder Rises on Q4 Beat, La-Z-Boy Sinks
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock’s biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.’s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday. - Shares of Estee Lauder (EL) rallied after the beauty company’s adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views. - Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker’s forecast sales for the second quarter missed the average analyst estimate. See omnystudio.com/listener for privacy information.
- Transcript
August 19 · 4 min
Target Posts Comp Sales Beat, Lowe's Slips on Outlook, Moderna Soars on Melanoma Study
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Shares of Target Corp. (TGT) dipped in the early session. That's despite the retail giant reported comparable sales for the second quarter that beat the average analyst estimate. The company also lifted its full-year guidance after results outpaced estimates in the latest quarter, suggesting the big-box retailer is moving past a lengthy sales slump. The company now expects net sales to increase about 5% in the current fiscal year, which ends in early 2027 — a percentage point higher than the previous guidance. - Shares of Lowe's Cos. (LOW) slipped in premarket trading after the company cut its outlook for the full year after posting results that missed Wall Street estimates, showing how a stubbornly weak housing market is eroding the home-improvement retailer’s performance. The company now expects comparable sales to be flat this fiscal year, after previously forecasting as much as 2% growth. Comparable sales, which measure results at locations open at least a year, grew 0.2% in the second quarter, missing the average of estimates compiled by Bloomberg. - Shares of Moderna (MRNA) surged as much as 80% in premarket trading after the company joined Merck (MRK) to announce their personalized cancer vaccine helped cut the recurrence of melanoma in a large, late-stage trial - an important milestone for the mRNA-based therapy. The trial met its main goal of showing that the vaccine, combined with Merck’s immune drug Keytruda, could lower the rate of melanoma recurrence, compared with the immunotherapy alone. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday. See omnystudio.com/listener for privacy information.
- Transcript
August 19 · 4 min
Trainline Dips, Smith & Nephew Falls, Straumann Drops
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Trainline shares fell as much as 17%, the most in five years, after the UK competition watchdog opened an investigation into whether the rail-booking platform breached consumer law through “drip pricing.” - Smith & Nephew shares drop to the lowest intraday level since May 12 after the medical devices maker said chief financial officer John Rogers will leave his position at the end of next month. Analysts suggest his departure will raise questions about the company’s outlook. - Straumann drops as much as 9.1%, the most in a year, after the Swiss dental implant maker said Christopher Norbye would replace Guillaume Daniellot as CEO. Analysts at Bernstein and JPMorgan said Daniellot was “well-liked,” with the news overshadowing the better-than-expected earnings for the first half-year. See omnystudio.com/listener for privacy information.
- Transcript
August 19 · 5 min
Carlsberg Dips, Frontline Rises, Smith & Nephew Drops
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Carlsberg volume growth was softer than expected in the first half, as subdued beer demand in Europe and Asia undermined a strong performance in soft drinks. - Shares in Frontline PLC which owns a fleet of large crude carriers are benefiting from elevated crude tanker rates due to uncertainty in the Strait of Hormuz. - Smith & Nephew shares drop as much as 3.7% to the lowest intraday level since May 12 after the medical devices maker said chief financial officer John Rogers will leave his position at the end of next month. Analysts suggest his departure will raise questions about the company’s outlook. See omnystudio.com/listener for privacy information.
- Transcript
August 19 · 5 min
Unitree Surges, Baidu Plummets, Xiaomi Rises
On this episode of Stock Movers: - Unitree Robotics shares opened 629% higher in their Shanghai trading debut after raising 6.1 billion yuan ($904 million) in an initial public offering that will make it the first publicly traded humanoid robot maker in mainland China. - Baidu shares slumped as much as 14.4% in Hong Kong, putting it on track for its worst day since 2022, after the Chinese search-engine operator’s revenue missed estimates and AI capex soared. - Xiaomi shares rise as much as 5% in Hong Kong after it reported smartphone revenue that was better than feared despite a global industry downturn. Its EV unit came under pressure from intense competition in China with Bernstein analysts saying management has lowered its full year EV sales target to 450,000 units. See omnystudio.com/listener for privacy information.
- Transcript
August 18 · 5 min
Targa Resources Rises, Meta Drops on Lawsuit, Duolingo Gains
On this episode of Stock Movers: - Targa Resources (TRGP) shares rose as much as 9.8% to a record high after the energy company signed new 20-year, fee-based integrated midstream agreements with ExxonMobil subsidiaries covering gathering, processing, NGL transportation, and fractionation across the Permian Basin through 2046. Targa also announced a new 70-mile expansion of its planned Bull Run natural gas pipeline network in the Permian Basin region. - Meta Platforms (META) is being sued by 29 states for allegedly deceiving the public by targeting children on Facebook and Instagram with technology designed to turn them into compulsive users and drive up advertising revenue. The states allege that Meta knowingly designed features that encouraged compulsive and prolonged use of its platforms by young people, while simultaneously misleading consumers about safety features on its platforms. - Duolingo (DUOL) shares are up after D.A. Davidson upgraded the language learning platform to buy from neutral citing a “turning point” in acceleration of daily active user metrics. See omnystudio.com/listener for privacy information.
- Transcript
August 18 · 5 min
Closing Bell: Amylyx Pharmaceuticals Climbs, Targa Rises, Klarna Plunges
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Scarlet Fu, Isabelle Lee, Carol Massar and Joe Deaux - Amylyx Pharmaceuticals (AMLX) shares climb as much as 43%, the most intraday since September 2022, after the drug developer said a late-stage trial of its experimental drug met its primary endpoint as a treatment for patients who experience dangerously low blood sugar levels following bariatric surgery. Stifel views the results as a “best-case scenario.” - Targa Resources (TRGP) shares rose 6.9% after the energy company signed new 20-year, fee-based integrated midstream agreements with ExxonMobil subsidiaries covering gathering, processing, NGL transportation, and fractionation across the Permian Basin through 2046. - Klarna (KLAR) shares are down more than 20% after the payments company reported full year revenue and gross merchandise value guidance that missed expectations. Active consumers for the second quarter also missed expectations. See omnystudio.com/listener for privacy information.
- Transcript
August 18 · 5 min
Klarna Plunges, Home Depot Gains, Duolingo Rises
Today's biggest winners and losers in the stock market, a look at the notable movers: On this episode of Stock Movers: - Klarna (KLAR) shares are down more than 20% after the payments company reported full year revenue and gross merchandise value guidance that missed expectations. Active consumers for the second quarter also missed expectations. - Home Depot (HD) results beat estimates in the latest quarter, a sign that spending on improvement projects is holding up despite high borrowing and housing costs. The company’s strategy, which includes expanding its business serving professional contractors and building out its e-commerce offerings, has helped to blunt the impact of a housing market weighed down by high home prices and interest rates. Home Depot experienced healthy demand across the US and product departments during the quarter, with portable power tools, live plants, and patio products being especially popular. - Duolingo (DUOL) shares are up after D.A. Davidson upgraded the language learning platform to buy from neutral citing a “turning point” in acceleration of daily active user metrics. See omnystudio.com/listener for privacy information.
- Transcript
August 18 · 2 min
Amer Sports Rises, Amylyx Jumps, and Klarna Plunges as FY Guidance Misses
On this episode of Stock Movers: - Amer Sports (AS) shares rise. The maker of Wilson tennis rackets and Salomon ski boots boosted its guidance for revenue growth and adjusted earnings per share for the full year. - Amylyx (AMLX) shares climb as much as 43%, the most intraday since September 2022, after the drug developer said a late-stage trial of its experimental drug met its primary endpoint as a treatment for patients who experience dangerously low blood sugar levels following bariatric surgery. Stifel views the results as a “best-case scenario.” - Klarna (KLAR) shares fell around after the payments company reported full year revenue and gross merchandise value guidance that missed expectations. Active consumers for the second quarter also missed expectations. See omnystudio.com/listener for privacy information.
- Transcript
August 18 · 2 min
Fabrinet Declines, Baidu ADRs Fall, Klarna Sinks as Guide Cut Overshadows 2Q Rev Beat
On this episode of Stock Movers: - Fabrinet (FN) shares fell. The process engineering and manufacturing services firm’s Datacom sales disappointed investors. The company also reported fourth-quarter results that beat expectations. - Baidu (BIDU) ADRs fall. The Chinese search-engine operator reported its fifth quarter of free cash outflow in the past six, thanks to soaring capital expenditures. It also reported AI-powered revenue that was weaker than analysts expected. - Klarna (KLAR) shares sink. The payments company slashed its full year revenue and gross merchandise value guidance, missing expectations. Active consumers for the second quarter also missed expectations. KBW said the key issue is the weaker second half outlook. See omnystudio.com/listener for privacy information.
- Transcript
August 18 · 3 min
Klarna Plunges, Amylyx Pharma Soars, Bath & Body Works Rallies
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Shares of Klarna (KLAR) plunged in premarket trading after the payments company reported full year revenue and gross merchandise value guidance that missed expectations. The company cited foreign exchange pressures and volumes in Germany, even as it reported a profit beat for the second straight quarter. The payments firm said in a statement that it expects between $4.08 billion and $4.16 billion of revenue this year, down from about $4.3 billion previously. Klarna said it had taken a “more measured view” of activity in Germany, its largest market by volumes. Active consumers for the second quarter also missed expectations. - Shares of Amylyx Pharmaceuticals (AMLX) extended its rally in the early session to as much as 54%, after the drug developer said a late-stage trial of its experimental drug met its primary endpoint as a treatment for patients who experience low blood sugar levels following bariatric surgery. Amylyx plans to submit a new drug application to the US Food & Drug Adminstration by end of 2026, targeting a potential commercial launch in 2027. - Shares of Bath & Body Works (BBWI) surged ahead of the opening bell after Citi raised its recommendation on the stock to buy from neutral. Analyst Paul Lejuez cited a favorable risk/reward outlook in his note. The company is slated to release earnings next week. See omnystudio.com/listener for privacy information.
- Transcript
August 18 · 4 min
Home Depot Gains on Earnings; Baidu Slips on Outflows; Alibaba Jumps
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Shares of Home Depot (HD) moved higher in the premarket session after posting an earnings beat in the latest quarter. Comparable sales, which measure results at stores open for at least a year, rose 1.7% during the period ended August 2nd, better than the average of analyst estimates and the highest since late 2022. Adjusted earnings also surpassed expectations. The stronger-than-expected report shows the company’s moves have helped to blunt the impact of a housing market that’s weighed down by high home prices and interest rates. - US-listed shares of Baidu (BIDU) declined in early trading after the Chinese search-engine operator reported its fifth quarter of free cash outflow in the past six, thanks to soaring capital expenditures. Its revenue was shy of analyst estimates, dragged by underperformance at its subsidiary iQiyi. Advertising is still the company's profit engine but has been shrinking for two years, but it now accounts for less than half of sales compared with the peak of about 90%. - US-listed shares of Alibaba (BABA) rallied ahead of Tuesday's opening bell after the launch of a new ecommerce platform boosted optimism toward the company before its June quarter earnings this week. Subsidiary Alipay rolled out a new “all-in-one” platform for businesses aimed at using AI agents to automate tasks. Alibaba shares have now rallied more than 40% from a low in June, rebounding from a selloff earlier this year. See omnystudio.com/listener for privacy information.
- Transcript
August 18 · 4 min
Frasers Group Up, Royal Unibrew Drops, OXB Down
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Frasers Group lifted its stake in Germany’s Hugo Boss to nearly 48%, falling short of taking full control, after only 17.6% of investors accepted its takeover offer. - Royal Unibrew reported EPS below estimates and sales in line with estimates. Trading volume was 376 times the average for this time of day. - OXB drops as much as 1.3% after Deutsche Bank downgraded the stock to hold from buy, saying the “burden of proof has shifted firmly towards execution” following the “disappointing” 1H trading update. See omnystudio.com/listener for privacy information.
- Transcript

Showing 301–320 of 428 episodes